Dr. Reddy's recalls 1mg Eszopiclone tablets due to potential impurities. Affected lots: C2302598, expiring 2/29/2025. No specific remedy stated in recall notice.
Failed Impurities/Degradation Specifications: Related Substances
Dr. Reddy's is recalling 1mg Eszopiclone tablets that may contain impurities. This could pose a risk to users, though the recall does not specify a remedy or how to check for affected products.
The tablets may contain impurities that could affect safety. This is a regulatory issue related to failed impurities and degradation specifications, but the exact health risk is not detailed in the recall notice.
Prescription users of Eszopiclone 1mg tablets from Dr. Reddy's Laboratories in India. Those with the specific lot number C2302598 (expiring 2/29/2025) are most at risk.
Check for the lot number C2302598 on the packaging. The product is a 1mg Eszopiclone tablet bottle with NDC 55111-629-30, manufactured in India and expiring 2/29/2025.
Look for the lot number C2302598 on the packaging of the Eszopiclone tablets.
The recall notice does not state any remedy or action to take.
The affected lot expires on 2/29/2025.
Check the lot number on the packaging; affected units have lot number C2302598.
We’ve drafted a message you can send Dr. Reddy's to request your refund or repair — edit it as you like.
Subject: Recall D-0581-2024 — Dr. Reddy's Dr. Reddy's Hello, I own a Dr. Reddy's that is covered by recall D-0581-2024 from Dr. Reddy's. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
